Cardiovascular disease in athletes

American Journal of Sports Medicine

Volumn 27, Issue 1, 1999, Pages 108-121

  Basilico, Frederick C ^a  

^a NEW ENGLAND BAPTIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATHLETE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; ELECTROCARDIOGRAM; EXERCISE; HUMAN; PHYSICAL ACTIVITY; PHYSICAL STRESS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; SPORTS MEDICINE; SUDDEN DEATH;

EID: 0032961686     PISSN: 03635465     EISSN: None     Source Type: Journal    
DOI: 10.1177/03635465990270010601     Document Type: Review

References (70)

1. Ackerman MJ: The long QT syndrome: Ion channel diseases of the heart. Mayo Clin Proc 73: 250-269, 1998
2. American Medical Association: Athletic preparticipation examinations for adolescents: Report of the Board of Trustees. Arch Pediatr Adolesc Med 148: 93-98, 1994
3. Atkins DL, Hartley LL, York DK: Accurate recognition and effective treatment of ventricular fibrillation by automated external defibrillators in adolescents. Pediatrics 101: 333-397, 1998
4. Bjornstad H, Smith G, Storstein L, et al: Electrocardiographic and echocardiographic findings in top athletes, athletic students and sedentary controls. Cardiology 82: 66-74, 1993
5. Bjornstad H, Storstein L, Meen HD, et al: Electrocardiographic findings of left, right and septal hypertrophy in athletic students and sedentary controls. Cardiology 82: 56-65, 1993
6. Braden DS, Strong WB: Preparticipation screening for sudden cardiac death in high school and college athletes. Physician Sportsmed 16(10): 128-144, 1988
7. Burke AP, Farb A, Virmani R, et al: Sports-related and non-sports-related sudden cardiac death in young adults. Am Heart J 121: 568-575, 1991
8. Calkins H, Shyr Y, Frumin H, et al: The value of the clinical history in the differentiation of syncope due to ventricular tachycardia, atrioventricular block, and neurocardiogenic syncope. Am J Med 98: 365-373, 1995
9. Cantu RC: Congenital cardiovascular disease: The major cause of athletic death in high school and college. Med Sci Sports Exerc 24: 279-280, 1992
10. Cheitlin MD, Douglas PS, Parmley WW: Task force 2: Acquired valvular heart disease, in Maron BJ, Mitchell JH (eds): 26th Bethesda conference: Recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. J Am Coll Cardiol 24: 874-880, 1994
11. Chu E, Cheitlin MD: Diagnostic considerations in patients with suspected coronary artery anomalies. Am Heart J 126: 1427-1438, 1993
12. Corrado D, Thiene G, Nava A, et al: Sudden death in young competitive athletes: Clinicopathologic correlations in 22 cases. Am J Med 89: 588-596, 1990
13. Emanuel R, Ng RA, Marcomichelakis J, et al: Formes frustes of Marfan's syndrome presenting with severe aortic regurgitation: Clinicogenetic study of 18 families. Br Heart J 39: 190-197, 1977
14. Fahrenbach MC, Thompson PD: The preparticipation sports examination: Cardiovascular considerations for screening. Cardiol Clin 10: 319-328, 1992
15. Feinstein RA, Colvin E, Oh MK: Echocardiographic screening as part of a preparticipation examination. Clin J Sport Med 3: 149-152, 1993
16. Fuller CM, McNulty CM, Spring DA, et al: Prospective screening of 5,615 high school athletes for risk of sudden cardiac death. Med Sci Sports Exerc 29: 1131-1138, 1997
17. Gallagher JJ, Gilbert M, Svenson RH, et al: Wolff-Parkinson-White syndrome: The problem, evaluation, and surgical correction. Circulation 51: 767-785, 1975
18. Glover DW, Maron BJ: Profile of preparticipation cardiovascular screening for high school athletes. JAMA 279: 1817-1819, 1998
19. Graham TP Jr, Bricker JT, James FW, et al: Task force 1: Congenital heart disease, in Maron BJ, Mitchell JH (eds): 26th Bethesda conference: Recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. J Am Coll Cardiol 24: 867-873, 1994
20. Grubb BP, Kosinski D, Pothoulakis A: Tilt-table testing for neurocardiogenic syncope. J Musculoskel Med 12(11): 37-44, 1995
21. Huston TP, Puffer JC, Rodney WM: The athletic heart syndrome. N Engl J Med 313: 24-32, 1985
22. Kapoor WN: Evaluation and management of the patient with syncope. JAMA 268: 2553-2560, 1992
23. Kerber RC, Becker LB, Bourland JD, et al: Automatic external defibrillators for public access defibrillation: Recommendations for specifying and reporting arrhythmia analysis algorithm performance, incorporating new waveforms, and enhancing safety. Circulation 95: 1677-1682, 1997
24. Klein GJ, Bashore TM, Sellers TD, et al: Ventricular fibrillation in the Wolff-Parkinson-White syndrome. N Engl J Med 301: 1080-1085, 1979
25. Klues HG, Schiffers A, Maron BJ: Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: Morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol 26: 1699-1708, 1995
26. Kohl HW III, Powell KE, Gordon NF, et al: Physical activity, physical fitness, and sudden cardiac death. Epidemiol Rev 14: 37-58, 1992
27. LaCorte MA, Boxer RA, Gottsfield IB, et al: EKG screening program for school athletes. Clin Cardiol 12: 42-44, 1989
28. Lewis JF, Maron BJ, Diggs JA, et al: Preparticipation echocardiographic screening for cardiovascular disease in a large, predominantly black population of collegiate athletes. Am J Cardiol 64: 1029-1033, 1989
29. Manolis AS, Linzer M, Salem D, et al: Syncope: Current diagnostic evaluation and management. Ann Intern Med 112: 850-863, 1990
30. Marcus FI, Fontaine G: Arrhythmogenic right ventricular dysplasia/cardiomyopathy: A review. Pacing Clin Etectrophysiol 18: 1298-1314, 1995
31. Maron BJ: Hypertrophic cardiomyopathy. Lancet 350: 127-133, 1997
32. Maron BJ: Sudden death in young athletes: Lessons from the Hank Gathers affair. N Engl J Med 329: 55-57, 1993
33. Maron BJ: Structural features of the athlete heart as defined by echocardiography. J Am Coll Cardiol 7: 190-203, 1986
34. Maron BJ, Bodison SA, Wesley YE, et al: Results of screening a large group of intercollegiate competitive athletes for cardiovascular disease. J Am Coll Cardiol 10: 1214-1221, 1987
35. Maron BJ, Epstein SE, Roberts WC: Causes of sudden death in competitive athletes. J Am Coll Cardiol 7: 204-214, 1986
36. Maron BJ, Goldenberg IF, Pedersen WR: Management of hypertrophic cardiomyopathy. Heart Dis Stroke 2: 203-208, 1993
37. Maron BJ, Isner JM, McKenna WJ: Task force 3: Hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse, in Maron BJ, Mitchell JH (eds): 26th Bethesda conference: Recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. J Am Coll Cardiol 24: 880-885, 1994
38. Maron BJ, Klues HG: Surviving competitive athletics with hypertrophic cardiomyopathy. Am J Cardiol 73: 1098-1104, 1994
39. Maron BJ, Mitchell JH (eds): 26th Bethesda conference: Recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. J Am Coll Cardiol 24: 845-899, 1994
40. Maron BJ, Mitchell JH: Revised eligibility recommendations for competitive athletes with cardiovascular abnormalities, in Maron BJ, Mitchell JH (eds): 26th Bethesda conference: Recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. J Am Coll Cardiol 24: 848-850, 1994
41. Maron BJ, Pelliccia A, Spirito P: Cardiac disease in young trained athletes: Insights into methods for distinguishing athlete's heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy. Circulation 91: 1596-1601, 1995
42. Maron BJ, Poliac LC, Roberts WO: Risk of sudden cardiac death associated with marathon running. J Am Coll Cardiol 28: 428-431, 1996
43. Maron BJ, Sharani J, Poliac LC, et al: Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. JAMA 276: 199-204, 1996
44. Maron BJ, Thompson PD, Puffer JC, et al: Cardiovascular preparticipation screening examination of competitive athletes: Addendum. Circulation 97: 2294, 1998
45. Maron BJ, Thompson PD, Puffer JC, et al: Cardiovascular preparticipation screening examination of competitive athletes. Circulation 94: 850-856, 1996
46. Matheson GO: Preparticipation screening of athletes (editorial). JAMA 279: 1829-1830, 1998
47. Mitchell JH, Haskell WL, Raven PB: Classification of sports, in Maron BJ, Mitchell JH (eds): 26th Bethesda conference: Recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. J Am Coll Cardiol 24: 864-866, 1994
48. Mitchell JH, Maron BJ, Epstein SE: 16th Bethesda conference: Cardiovascular abnormalities in the athlete: Recommendations regarding eligibility for competition. J Am Coll Cardiol 6: 1186-1232, 1985
49. Moss AJ, Behnorin J: QT interval prolongation: Basic considerations and clinical consequences, in Braunwald E (ed): Heart Disease: A Textbook of Cardiovascular Medicine - Updates. Philadelphia, WB Saunders, 1993, pp 1-9
50. Murry PM, Cantwell JD, Heath DL, et al: The role of limited echocardiography in screening athletes. Am J Cardiol 76: 849-850, 1995
51. Myerburg RJ, Kessler KM, Castellanos A: Sudden cardiac death: Epidemiology, transient risk, and intervention assessment. Ann Intern Med 119: 1187-1197, 1993
52. Myerburg RJ, Kessler KM, Castellanos A: Sudden cardiac death: Structure, function, and time-dependence of risk. Circulation 85(suppl 1): 1-2-1-10, 1992
53. Pelliccia A, Maron BJ, Culasso F, et al: Athlete's heart in women: Echcardiographic characterization of highly trained elite female athletes. JAMA 276: 211-215, 1996
54. Pelliccia A, Maron BJ, Spataro A, et al: The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med 324: 295-301, 1991
55. Roden DM, Lazzara R, Rosen M, et al: Multiple mechanisms in the Long-QT syndrome: Current knowledge, gaps, and future directions. Circulation 94: 1996-2012, 1996
56. Ryan MP, Cleland JG, French JA, et al: The standard electrocardiogram as a screening test for hypertrophic cardiomyopathy. Am J Cardiol 76: 689-694, 1995
57. Scheller A Jr, Rask B: A protocol for the health and fitness assessment of NBA players. Clin Sports Med 12: 193-205, 1993
58. Siscovick DS, Weiss NS, Fletcher RH, et al: The incidence of primary cardiac arrest during vigorous exercise. N Engl J Med 311: 874-877, 1984
59. Spirito P, Seidman CE, McKenna WJ, et al: The management of hypertrophic cardiomyopathy. N Engl J Med 336: 775-785, 1997
60. Tan HL, Hou CJ, Lauer MR, et al: Electrophysiologic mechanisms of the Long QT interval syndromes and torsades de pointes. Ann Intern Med 122: 701-714, 1995
61. Thompson PD: The cardiovascular complications of vigorous physical activity. Arch Intern Med 156: 2297-2302, 1996
62. Thompson PD, Funk EJ, Carleton RA, et al: Incidence of death during jogging in Rhode Island from 1975 through 1980. JAMA 247: 2535-2538, 1982
63. Thompson PD, Klocke FJ, Levine BD, et al: Task Force 5: Coronary artery disease, in Maron BJ, Mitchell JH (eds): 26th Bethesda conference: Recommendations tor determining eligibility for competition in athletes with cardiovascular abnormalities. J Am Coll Cardiol 24: 888-892, 1994
64. Van Camp SP, Bloor CM, Mueller FO, et al: Nontraumatic sports death in high school and college athletes. Med Sci Sports Exerc 27: 641-647, 1995
65. Waller BF: Exercise-related sudden death in young (age ≤30 years) and old (age >30 years) conditioned athletes, in Wenger NK (ed): Exercise and the Heart. Philadelphia, FA Davis, 1985, pp 9-73
66. Weidenbener EJ, Krauss MD, Waller BF, et al: Incorporation of screening echocardiography in the preparticipation exam. Clin J Sport Med 5: 86-89, 1995
67. Wight JN Jr, Salem D: Sudden cardiac death and the "athlete's heart." Arch Intern Med 155: 1473-1480, 1995
68. Winget JF, Capeless MA, Ades PA: Sudden death in athletes. Sports Med 18: 375-383, 1994
69. Zehender M, Meinertz T, Keul J, et al: ECG variants and cardiac arrhythmias in athletes: Clinical relevance and prognostic importance. Am Heart J 119: 1378-1391, 1990
70. Zipes DP, Garson A Jr: Task force 6: Arrhythmias, in Maron BJ, Mitchell JH (eds): 26th Bethesda conference: Recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. J Am Coll Cardiol 24: 892-899, 1994